Comparing Dialectical Behavior Therapy with Prolonged Exposure to Standard Prolonged Exposure Therapy for Veterans with PTSD and Suicide Risk
Led by VA Office of Research and Development · Updated on 2026-07-16
125
Participants Needed
4
Research Sites
69 weeks
Total Duration
AI-Summary
What this Trial Is About
Posttraumatic Stress Disorder PTSD significantly increases suicide risk among Veterans, especially those who have engaged in self-directed violence SDV. This study evaluates two treatments for Veterans with PTSD and high suicide risk a combination of Dialectical Behavior Therapy DBT plus DBT Prolonged Exposure DBT PE, and Prolonged Exposure therapy with suicide risk management PE SRM, the current standard care. The trial aims to fill a critical knowledge gap by comparing these approaches and examining factors affecting their implementation in VA settings.
Participants receive either one year of standard DBT combined with the DBT PE protocol or up to 18 sessions of Prolonged Exposure therapy augmented with suicide risk management. DBT includes individual therapy, group skills training, coaching, and team consultation, while DBT PE and PE involve in vivo and imaginal exposure with processing delivered in weekly individual therapy sessions. The study is a multi-site randomized controlled trial conducted in outpatient VA clinics, with assessments over 16 months.
During the study, Veterans are assessed at five time points for self-injurious thoughts and behaviors, PTSD severity, suicide ideation, emotion regulation, mental health, and disability. Researchers use interviews, questionnaires, and clinical scales to measure outcomes and gather information on treatment engagement and implementation barriers. The total participation spans 16 months with ongoing monitoring to evaluate the effectiveness and feasibility of these therapies for high-risk Veterans.
CONDITIONS
Brief Title
Evaluating Treatments for Suicidal Veterans With PTSD
Research Team
M
Melanie S Harned, PhD
J
John C Fortney, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
An integrated therapy combining standard Dialectical Behavior Therapy with the DBT Prolonged Exposure protocol for PTSD
Prolonged Exposure therapy combined with VA suicide risk management procedures
Trauma‑focused individual psychotherapy such as Prolonged Exposure or Cognitive Processing Therapy, per VA/DoD guidelines
Role in the trial
Investigational treatment arm
Active comparator arm reflecting standard‑of‑care augmented with suicide risk management
Represents guideline‑recommended PTSD therapy outside the trial
Purpose
To treat PTSD symptoms and reduce self‑directed violence in high‑risk veterans
To treat PTSD and manage suicide risk according to current VA standard practices
To reduce PTSD symptoms using evidence‑based trauma‑focused psychotherapy
How it is delivered
Delivered as DBT individual and group sessions plus coaching, with integrated PE (1.5 h/week)
Delivered as individual PE sessions (1.5 h/week) alongside suicide risk assessment and safety planning
Delivered individually according to evidence‑based protocols (typically weekly sessions)
Evidence status
Preliminary studies suggest combining DBT + PE is feasible, acceptable and may reduce PTSD and self‑directed violence, but large‑scale evidence is pending
Prolonged Exposure with suicide risk management aligns with current VA best practice though direct evidence for high‑risk suicidal veterans is limited
Trauma‑focused therapies such as PE and CPT are strongly evidence‑based for reducing PTSD symptoms
Important limitations
Effectiveness in broader veteran populations pending; large‑scale randomized results not yet available
Evidence specific to suicidal veterans receiving PE + SRM is limited, though PE is evidence‑based generally
Guideline‑based therapies reduce PTSD but their impact on acute suicidality in high‑risk groups is less established
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Diagnosis of PTSD
Recent and repeated self-directed violence
Current suicidal ideation
Emotion dysregulation
Veteran eligible for VA mental health care at participating site
Willing to participate in all study activities
You will not qualify if you...
Unable to maintain safety independently
Currently engaged in or recent (past year) history of sufficient Dialectical Behavior Therapy or Prolonged Exposure therapy
Plan to move away or be unavailable for more than 4 weeks in the next 18 months
Unable to understand study procedures due to lack of English proficiency or moderate to severe cognitive impairment
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 12 months
Participants receive either Dialectical Behavior Therapy combined with DBT Prolonged Exposure or Prolonged Exposure therapy with suicide risk management, delivered in weekly individual therapy sessions.
Weekly therapy sessions
Follow-up
Duration - Up to 16 months
Participants are assessed at multiple points over 16 months to measure PTSD symptoms, suicidal behaviors, emotion regulation, mental health, and disability.
5 assessment visits
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Pilot Study of Blended Trauma-Focused Cognitive Behavioral Therapy with Compassion for Adolescents Aged 12-17 with PTSD in Northern Sweden
Study of Psilocybin and Structured Integrated Reframing Therapy for Trauma-Related Major Depressive Disorder
Evaluating Effects on Gut-Brain Biomarkers and Depression Symptoms
Pilot Study of Combined EMDR Group and Individual Therapy for Adults with Advanced Thyroid Cancer
Comparing Dialectical Behavior Therapy with Prolonged Exposure to Standard Prolonged Exposure Therapy for Veterans with PTSD and Suicide Risk
A Phase 2 Study Testing Intranasal Oxytocin Added to Couples Therapy for Veterans With PTSD to Improve Symptoms and Relationships
One-Year Follow-Up Study of Children and Adolescents Exposed to Trauma
Evaluating PTSD and Complex PTSD Diagnoses and Translating a Trauma Assessment Tool into Turkish
Study of Ketamine to Improve Pain, Reduce Opioid Use, and Support Mental Health in Adults Undergoing Orthopedic Trauma Surgery
Studying NightWare Wrist Device to Improve Sleep and Heart Health in Veterans With PTSD Nightmares
Evaluating the Safety and Effectiveness of the gammaCore Handheld Vagus Nerve Stimulation Device
for Treating Post-Traumatic Stress Disorder PTSD Symptoms in Adults
Studying Complex PTSD in Children and Teens Who Have Experienced Trauma and Related Factors
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Evaluating psychotherapies for veterans with PTSD at elevated acute risk of suicide: Protocol for a multi-site type 1 hybrid effectiveness-implementation trial.
Melanie S Harned, C Beth Ready, Lindsay M Andrews Wiebusch...